D-xylo-Hexaric acid,3,4-dideoxy-2-C-ethyl-4-methyl-5-C-methyl- (9CI) (30000-37-4)

Identification
Name:	D-xylo-Hexaric acid,3,4-dideoxy-2-C-ethyl-4-methyl-5-C-methyl- (9CI)
Synonyms:	Hexanedioicacid, 5-ethyl-2,5-dihydroxy-2,3-dimethyl-, [2S-(2R,3S,5R*)]-; Isolinecic acid(8CI)
CAS:	30000-37-4
Molecular Formula:	C10H18 O6
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

D-xylo-Hexaric acid,3,4-dideoxy-2-C-ethyl-4-methyl-5-C-methyl-, 1,5-lactone (9CI)
D-xylo-Hexaric acid,3,4-dideoxy-2-C-ethyl-4-methyl-5-C-methyl-, 6,2-lactone (9CI)
L-arabino-Hexaric acid,3,4-dideoxy-2-C-[(1R)-1-hydroxyethyl]-4-methyl-5-C-methyl- (9CI)
D-xylo-Hept-2-enonic acid,2,3-dideoxy-4-O-ethyl-7-C-phenyl-,ä-lactone,(7R)-
Spiro[2,13-methano-10H-anthra[1,2-b]-1,3-dioxolo[4,5-d]pyran-14,2'-oxiran]-10-one,7-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-a-L-xylo-hexopyranosyl)oxy]-13-[[2,6-dideoxy-4-C-(1-hydroxyethyl)-a-L-xylo-hexopyranosyl]oxy]-2-(dimethoxymethyl)-3a,7,8,9,13,13a-hexahydro-9,11-dihydroxy-6-methoxy-4-methyl-,(2R,2'S,3aS,7S,9S,13S,13aS)- (9CI)
D-ribo-Hexaric acid,2,5-anhydro-3,4,6- trideoxy-3-methyl-2,5-di-C-methyl-
Leuconolide,5-O-(3-C-acetyl-4,6-dideoxy-b-D-xylo-hexopyranosyl)-18-deoxo- (9CI)
xylo-Hexose,2,6-dideoxy-3-C-methyl-3-O-methyl-
3-C-Methyl-3-O-methyl-2,6-dideoxy-D-xylo-hexopyranose
3-C-Methyl-2,6-dideoxy-L-xylo-hexose
Rubradirin B,4''-[(2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-a-D-xylo-hexopyranosyl)oxy]-,(7Z)- (9CI)
L-threo-Pentaric acid,2-carboxy-2,3-dideoxy-2-ethyl-3-methyl-4-C-methyl-, 1,4-lactone, (2S)- (9CI)
15-O-(4-O-Acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-xylo-hexopyranosyl)lankamycin
a-L-xylo-3-Hexulofuranosidonicacid, b-D-glucopyranosyl2-C-[(1R)-2-carboxy-1-(4-hydroxyphenyl)ethyl]-, 1,4-lactone (9CI)
Pentonic acid, 2,3-anhydro-4,5-dideoxy-2-C-ethyl-4-methyl- (9CI)
1-Oxa-4-azacyclotridecan-13-one,11-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-a-L-ribo-hexopyranosyl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(2R,3R,6R,8R,9R,10S,11S,12R)- (9CI)
Oxacyclotetradecane-2,10-dione,4-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-xylo-hexopyranosyl)oxy]-12-(acetyloxy)-6-[(4,6-dideoxy-3-O-methyl-b-D-xylo-hexopyranosyl)oxy]-9-hydroxy-14-[(1S,2S)-2-hydroxy-1-methylpropyl]-3,5,7,9,11,13-hexamethyl-,(3R,4S,5R,6S,7S,9S,11R,12S,13S,14R)-
1-Oxa-6-azacyclopentadecan-15-one,13-[[2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-a-L-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-
a-L-xylo-3-Hexulofuranosonic acid,2-C-[(1-ethyl-1H-indol-3-yl)methyl]-, g-lactone (9CI)
Spiro[1,4-methanoanthra[2,3-d]oxepin-2(1H),2'(1'H)-pyrrolo[2,3-b]pyrrole]-7,12-dione,5-[[2,6-dideoxy-4-C-(1-hydroxyethyl)-a-L-xylo-hexopyranosyl]oxy]-4,4',5,5'-tetrahydro-8,13-dihydroxy-4-methyl-,(1S,2R,4R,5R)-